Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
96% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.46 vs. ICUI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ICUI' s Cash to Debt Range Over the Past 10 Years
Min: N/A  Med: No Debt Max: No Debt
Current: No Debt
N/A
No Debt
Equity to Asset 0.94
ICUI's Equity to Asset is ranked higher than
99% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. ICUI: 0.94 )
Ranked among companies with meaningful Equity to Asset only.
ICUI' s Equity to Asset Range Over the Past 10 Years
Min: 0.85  Med: 0.92 Max: 0.96
Current: 0.94
0.85
0.96
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
95% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.78 vs. ICUI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ICUI' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
F-Score: 7
Z-Score: 47.14
M-Score: -0.75
WACC vs ROIC
6.05%
25.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 21.83
ICUI's Operating margin (%) is ranked higher than
89% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.41 vs. ICUI: 21.83 )
Ranked among companies with meaningful Operating margin (%) only.
ICUI' s Operating margin (%) Range Over the Past 10 Years
Min: 12.62  Med: 16.48 Max: 21.83
Current: 21.83
12.62
21.83
Net-margin (%) 15.18
ICUI's Net-margin (%) is ranked higher than
83% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.23 vs. ICUI: 15.18 )
Ranked among companies with meaningful Net-margin (%) only.
ICUI' s Net-margin (%) Range Over the Past 10 Years
Min: 8.52  Med: 12.5 Max: 15.18
Current: 15.18
8.52
15.18
ROE (%) 9.44
ICUI's ROE (%) is ranked higher than
63% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. ICUI: 9.44 )
Ranked among companies with meaningful ROE (%) only.
ICUI' s ROE (%) Range Over the Past 10 Years
Min: 5.41  Med: 10.47 Max: 15.02
Current: 9.44
5.41
15.02
ROA (%) 8.80
ICUI's ROA (%) is ranked higher than
77% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. ICUI: 8.80 )
Ranked among companies with meaningful ROA (%) only.
ICUI' s ROA (%) Range Over the Past 10 Years
Min: 5.06  Med: 9.36 Max: 13.27
Current: 8.8
5.06
13.27
ROC (Joel Greenblatt) (%) 48.30
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. ICUI: 48.30 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ICUI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 23.87  Med: 31.56 Max: 48.3
Current: 48.3
23.87
48.3
Revenue Growth (3Y)(%) -1.30
ICUI's Revenue Growth (3Y)(%) is ranked lower than
68% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. ICUI: -1.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ICUI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.5  Med: 14.9 Max: 34.6
Current: -1.3
-2.5
34.6
EBITDA Growth (3Y)(%) -1.20
ICUI's EBITDA Growth (3Y)(%) is ranked lower than
68% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. ICUI: -1.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ICUI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.8  Med: 15.1 Max: 35
Current: -1.2
-19.8
35
EPS Growth (3Y)(%) -0.80
ICUI's EPS Growth (3Y)(%) is ranked lower than
65% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.50 vs. ICUI: -0.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ICUI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -32.2  Med: 12.7 Max: 66
Current: -0.8
-32.2
66
GuruFocus has detected 5 Warning Signs with ICU Medical Inc $ICUI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ICUI Guru Trades in Q1 2016

Ken Fisher 31,000 sh (New)
Paul Tudor Jones 7,031 sh (+20.99%)
Jim Simons 842,000 sh (+3.59%)
Mario Gabelli 70,500 sh (unchged)
Joel Greenblatt 40,595 sh (-3.72%)
» More
Q2 2016

ICUI Guru Trades in Q2 2016

Joel Greenblatt 41,529 sh (+2.30%)
Ken Fisher 31,000 sh (unchged)
Mario Gabelli 70,500 sh (unchged)
Jim Simons 793,100 sh (-5.81%)
Paul Tudor Jones 3,757 sh (-46.57%)
» More
Q3 2016

ICUI Guru Trades in Q3 2016

Joel Greenblatt 55,374 sh (+33.34%)
Paul Tudor Jones 4,251 sh (+13.15%)
Ken Fisher 31,000 sh (unchged)
Mario Gabelli 70,500 sh (unchged)
Jim Simons 739,000 sh (-6.82%)
» More
Q4 2016

ICUI Guru Trades in Q4 2016

Jim Simons 739,700 sh (+0.09%)
Ken Fisher 31,000 sh (unchged)
Paul Tudor Jones Sold Out
Mario Gabelli 70,400 sh (-0.14%)
Joel Greenblatt 32,098 sh (-42.03%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:PODD, NYSE:CMD, OTCPK:ANSLY, OTCPK:GNGBY, NYSE:HAE, NYSE:HYH, NAS:NXTM, OTCPK:TOPCF, NYSE:HRC, NYSE:GKOS, NAS:MMSI, NAS:ATRI, NAS:IRTC, NAS:LMNX, NAS:NVCR, OTCPK:NNCSF, NAS:OSUR, NAS:ANGO, NAS:ATRC, NAS:ELGX » details
Traded in other countries:IC7.Germany,
ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.

ICU Medical Inc is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").

Ratios

vs
industry
vs
history
P/E(ttm) 45.75
ICUI's P/E(ttm) is ranked lower than
75% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.87 vs. ICUI: 45.75 )
Ranked among companies with meaningful P/E(ttm) only.
ICUI' s P/E(ttm) Range Over the Past 10 Years
Min: 13.76  Med: 23.31 Max: 52.73
Current: 45.75
13.76
52.73
Forward P/E 31.85
ICUI's Forward P/E is ranked lower than
75% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.15 vs. ICUI: 31.85 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 45.75
ICUI's PE(NRI) is ranked lower than
77% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. ICUI: 45.75 )
Ranked among companies with meaningful PE(NRI) only.
ICUI' s PE(NRI) Range Over the Past 10 Years
Min: 13.78  Med: 23.31 Max: 52.73
Current: 45.75
13.78
52.73
Price/Owner Earnings (ttm) 69.82
ICUI's Price/Owner Earnings (ttm) is ranked lower than
83% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.26 vs. ICUI: 69.82 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ICUI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 10.76  Med: 23.21 Max: 86.38
Current: 69.82
10.76
86.38
P/B 3.87
ICUI's P/B is ranked lower than
54% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. ICUI: 3.87 )
Ranked among companies with meaningful P/B only.
ICUI' s P/B Range Over the Past 10 Years
Min: 1.4  Med: 2.19 Max: 3.88
Current: 3.87
1.4
3.88
P/S 6.90
ICUI's P/S is ranked lower than
80% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.96 vs. ICUI: 6.90 )
Ranked among companies with meaningful P/S only.
ICUI' s P/S Range Over the Past 10 Years
Min: 1.73  Med: 2.9 Max: 6.92
Current: 6.9
1.73
6.92
PFCF 48.61
ICUI's PFCF is ranked lower than
72% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.37 vs. ICUI: 48.61 )
Ranked among companies with meaningful PFCF only.
ICUI' s PFCF Range Over the Past 10 Years
Min: 11.13  Med: 26.67 Max: 99.73
Current: 48.61
11.13
99.73
POCF 34.72
ICUI's POCF is ranked lower than
78% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.55 vs. ICUI: 34.72 )
Ranked among companies with meaningful POCF only.
ICUI' s POCF Range Over the Past 10 Years
Min: 9.21  Med: 14.92 Max: 34.81
Current: 34.72
9.21
34.81
EV-to-EBIT 32.11
ICUI's EV-to-EBIT is ranked lower than
67% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.36 vs. ICUI: 32.11 )
Ranked among companies with meaningful EV-to-EBIT only.
ICUI' s EV-to-EBIT Range Over the Past 10 Years
Min: 7  Med: 13 Max: 32.21
Current: 32.11
7
32.21
EV-to-EBITDA 26.00
ICUI's EV-to-EBITDA is ranked lower than
77% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.65 vs. ICUI: 26.00 )
Ranked among companies with meaningful EV-to-EBITDA only.
ICUI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 9 Max: 26.09
Current: 26
5.4
26.09
Shiller P/E 61.11
ICUI's Shiller P/E is ranked lower than
77% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 41.26 vs. ICUI: 61.11 )
Ranked among companies with meaningful Shiller P/E only.
ICUI' s Shiller P/E Range Over the Past 10 Years
Min: 17.58  Med: 29.59 Max: 61.29
Current: 61.11
17.58
61.29
Current Ratio 15.47
ICUI's Current Ratio is ranked higher than
98% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.39 vs. ICUI: 15.47 )
Ranked among companies with meaningful Current Ratio only.
ICUI' s Current Ratio Range Over the Past 10 Years
Min: 5.86  Med: 10.23 Max: 22.75
Current: 15.47
5.86
22.75
Quick Ratio 13.90
ICUI's Quick Ratio is ranked higher than
97% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. ICUI: 13.90 )
Ranked among companies with meaningful Quick Ratio only.
ICUI' s Quick Ratio Range Over the Past 10 Years
Min: 4.57  Med: 9.42 Max: 21.41
Current: 13.9
4.57
21.41
Days Inventory 97.69
ICUI's Days Inventory is ranked higher than
69% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.69 vs. ICUI: 97.69 )
Ranked among companies with meaningful Days Inventory only.
ICUI' s Days Inventory Range Over the Past 10 Years
Min: 47.92  Med: 84.94 Max: 101.19
Current: 97.69
47.92
101.19
Days Sales Outstanding 52.34
ICUI's Days Sales Outstanding is ranked higher than
68% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.60 vs. ICUI: 52.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICUI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.09  Med: 54.66 Max: 75.32
Current: 52.34
46.09
75.32
Days Payable 26.16
ICUI's Days Payable is ranked lower than
87% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 49.38 vs. ICUI: 26.16 )
Ranked among companies with meaningful Days Payable only.
ICUI' s Days Payable Range Over the Past 10 Years
Min: 24.54  Med: 26.17 Max: 54.81
Current: 26.16
24.54
54.81

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.60
ICUI's 3-Year Average Share Buyback Ratio is ranked lower than
54% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.80 vs. ICUI: -3.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ICUI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.6  Med: -1.4 Max: 2
Current: -3.6
-4.6
2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 7.52
ICUI's Price/Net Cash is ranked higher than
65% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.50 vs. ICUI: 7.52 )
Ranked among companies with meaningful Price/Net Cash only.
ICUI' s Price/Net Cash Range Over the Past 10 Years
Min: 3.3  Med: 5.69 Max: 575
Current: 7.52
3.3
575
Price/Net Current Asset Value 5.39
ICUI's Price/Net Current Asset Value is ranked higher than
60% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.51 vs. ICUI: 5.39 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ICUI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.72  Med: 3.42 Max: 5.42
Current: 5.39
1.72
5.42
Price/Tangible Book 4.03
ICUI's Price/Tangible Book is ranked higher than
59% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.64 vs. ICUI: 4.03 )
Ranked among companies with meaningful Price/Tangible Book only.
ICUI' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.31  Med: 2.41 Max: 4.06
Current: 4.03
1.31
4.06
Price/Projected FCF 2.72
ICUI's Price/Projected FCF is ranked lower than
63% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. ICUI: 2.72 )
Ranked among companies with meaningful Price/Projected FCF only.
ICUI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.79  Med: 1.58 Max: 2.73
Current: 2.72
0.79
2.73
Price/Median PS Value 2.38
ICUI's Price/Median PS Value is ranked lower than
88% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. ICUI: 2.38 )
Ranked among companies with meaningful Price/Median PS Value only.
ICUI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.12 Max: 2.45
Current: 2.38
0.6
2.45
Price/Graham Number 2.86
ICUI's Price/Graham Number is ranked lower than
52% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. ICUI: 2.86 )
Ranked among companies with meaningful Price/Graham Number only.
ICUI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.91  Med: 1.59 Max: 3.7
Current: 2.86
0.91
3.7
Earnings Yield (Greenblatt) (%) 3.06
ICUI's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. ICUI: 3.06 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ICUI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.05  Med: 7.7 Max: 14.3
Current: 3.06
3.05
14.3
Forward Rate of Return (Yacktman) (%) 0.37
ICUI's Forward Rate of Return (Yacktman) (%) is ranked lower than
70% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.86 vs. ICUI: 0.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ICUI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.1  Med: 12.7 Max: 27.3
Current: 0.37
-2.1
27.3

More Statistics

Revenue (TTM) (Mil) $374.1
EPS (TTM) $ 3.35
Beta0.48
Short Percentage of Float6.01%
52-Week Range $88.00 - 154.80
Shares Outstanding (Mil)19.53

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 378 872 1,437 1,494
EPS ($) 4.63 4.79 6.85 8.45
EPS w/o NRI ($) 4.63 4.79 6.85 8.45
EPS Growth Rate
(3Y to 5Y Estimate)
19.20%
Dividends Per Share ($)
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
EW: Potential for Capital Appreciation Oct 03 2014 
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 

More From Other Websites
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2016 Earnings Conference Call Feb 21 2017
Integrating ICU Medical Infusion Devices with Hospital Electronic Medical Records Decreased Major... Feb 15 2017
ICU MEDICAL INC/DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Feb 09 2017
ICU Medical, Inc. breached its 50 day moving average in a Bullish Manner : ICUI-US : February 8,... Feb 08 2017
ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer Feb 06 2017
Align Poised On Global Expansion & Invisalign Teen Growth Jan 11 2017
Illumina (ILMN) Launches NovaSeq Series for $100 Genome Jan 10 2017
QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite Jan 10 2017
ICU Medical shares keep climbing as BlackRock ups stake to more than 10% Jan 09 2017
LLabCorp: Reimbursement Scenario a Drag Amid Other Woes Jan 09 2017
ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders Jan 09 2017
ICU MEDICAL INC/DE Files SEC form 8-K, Change in Directors or Principal Officers Jan 06 2017
ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit Jan 06 2017
ICU Medical, Inc. to Present at 35th Annual J.P. Morgan Healthcare Conference Jan 06 2017
Myriad Genetics: Evidence Street Reviews EndoPredict Test Jan 06 2017
ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction Jan 05 2017
ICU MEDICAL INC/DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jan 05 2017
ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction Jan 05 2017
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View Jan 05 2017
Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite Jan 05 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)